Lv4
490 积分 2025-01-06 加入
CheckMate 012: Safety and efficacy of first-line (1L) nivolumab (nivo; N) and ipilimumab (ipi; I) in advanced (adv) NSCLC
8小时前
求助中
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
18天前
已完结
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
18天前
已完结
A critical role for the programmed death ligand 1 in fetomaternal tolerance
18天前
已完结
A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma
1个月前
已完结
Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial
1个月前
已完结
NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway
3个月前
已完结
皖公网安备34019202002308
